Transplantation of insulin-producing cells from umbilical cord mesenchymal stem cells for the treatment of streptozotocin-induced diabetic rats

Pei Jiun Tsai, Hwai Shi Wang, Yi Ming Shyr, Zen Chung Weng, Ling Chen Tai, Jia Fwu Shyu, Tien Hua Chen

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Background: Although diabetes mellitus (DM) can be treated with islet transplantation, a scarcity of donors limits the utility of this technique. This study investigated whether human mesenchymal stem cells (MSCs) from umbilical cord could be induced efficiently to differentiate into insulin-producing cells. Secondly, we evaluated the effect of portal vein transplantation of these differentiated cells in the treatment of streptozotocin-induced diabetes in rats. Methods: MSCs from human umbilical cord were induced in three stages to differentiate into insulin-producing cells and evaluated by immunocytochemistry, reverse transcriptase, and real-time PCR, and ELISA. Differentiated cells were transplanted into the liver of diabetic rats using a Port-A catheter via the portal vein. Blood glucose levels were monitored weekly. Results: Human nuclei and C-peptide were detected in the rat liver by immunohistochemistry. Pancreatic ?-cell development-related genes were expressed in the differentiated cells. C-peptide release was increased after glucose challenge in vitro. Furthermore, after transplantation of differentiated cells into the diabetic rats, blood sugar level decreased. Insulin-producing cells containing human C-peptide and human nuclei were located in the liver. Conclusion: Thus, a Port-A catheter can be used to transplant differentiated insulin-producing cells from human MSCs into the portal vein to alleviate hyperglycemia among diabetic rats.

Original languageEnglish
Article number47
JournalJournal of Biomedical Science
Volume19
Issue number1
DOIs
Publication statusPublished - 2012

Fingerprint

Umbilical Cord
Streptozocin
Stem cells
Mesenchymal Stromal Cells
Rats
Transplantation
Insulin
C-Peptide
Liver
Catheters
Portal Vein
Medical problems
Vascular Access Devices
Blood Glucose
Cell Transplantation
Therapeutics
Transplants
RNA-Directed DNA Polymerase
Immunohistochemistry
Islets of Langerhans Transplantation

Keywords

  • Insulin-producing cells
  • Mesenchymal stem cell
  • Portal vein
  • Transplant

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Molecular Biology
  • Cell Biology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism
  • Pharmacology (medical)

Cite this

Transplantation of insulin-producing cells from umbilical cord mesenchymal stem cells for the treatment of streptozotocin-induced diabetic rats. / Tsai, Pei Jiun; Wang, Hwai Shi; Shyr, Yi Ming; Weng, Zen Chung; Tai, Ling Chen; Shyu, Jia Fwu; Chen, Tien Hua.

In: Journal of Biomedical Science, Vol. 19, No. 1, 47, 2012.

Research output: Contribution to journalArticle

Tsai, Pei Jiun ; Wang, Hwai Shi ; Shyr, Yi Ming ; Weng, Zen Chung ; Tai, Ling Chen ; Shyu, Jia Fwu ; Chen, Tien Hua. / Transplantation of insulin-producing cells from umbilical cord mesenchymal stem cells for the treatment of streptozotocin-induced diabetic rats. In: Journal of Biomedical Science. 2012 ; Vol. 19, No. 1.
@article{dfe1a3807d1145278250d5f8f1394272,
title = "Transplantation of insulin-producing cells from umbilical cord mesenchymal stem cells for the treatment of streptozotocin-induced diabetic rats",
abstract = "Background: Although diabetes mellitus (DM) can be treated with islet transplantation, a scarcity of donors limits the utility of this technique. This study investigated whether human mesenchymal stem cells (MSCs) from umbilical cord could be induced efficiently to differentiate into insulin-producing cells. Secondly, we evaluated the effect of portal vein transplantation of these differentiated cells in the treatment of streptozotocin-induced diabetes in rats. Methods: MSCs from human umbilical cord were induced in three stages to differentiate into insulin-producing cells and evaluated by immunocytochemistry, reverse transcriptase, and real-time PCR, and ELISA. Differentiated cells were transplanted into the liver of diabetic rats using a Port-A catheter via the portal vein. Blood glucose levels were monitored weekly. Results: Human nuclei and C-peptide were detected in the rat liver by immunohistochemistry. Pancreatic ?-cell development-related genes were expressed in the differentiated cells. C-peptide release was increased after glucose challenge in vitro. Furthermore, after transplantation of differentiated cells into the diabetic rats, blood sugar level decreased. Insulin-producing cells containing human C-peptide and human nuclei were located in the liver. Conclusion: Thus, a Port-A catheter can be used to transplant differentiated insulin-producing cells from human MSCs into the portal vein to alleviate hyperglycemia among diabetic rats.",
keywords = "Insulin-producing cells, Mesenchymal stem cell, Portal vein, Transplant",
author = "Tsai, {Pei Jiun} and Wang, {Hwai Shi} and Shyr, {Yi Ming} and Weng, {Zen Chung} and Tai, {Ling Chen} and Shyu, {Jia Fwu} and Chen, {Tien Hua}",
year = "2012",
doi = "10.1186/1423-0127-19-47",
language = "English",
volume = "19",
journal = "Journal of Biomedical Science",
issn = "1021-7770",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Transplantation of insulin-producing cells from umbilical cord mesenchymal stem cells for the treatment of streptozotocin-induced diabetic rats

AU - Tsai, Pei Jiun

AU - Wang, Hwai Shi

AU - Shyr, Yi Ming

AU - Weng, Zen Chung

AU - Tai, Ling Chen

AU - Shyu, Jia Fwu

AU - Chen, Tien Hua

PY - 2012

Y1 - 2012

N2 - Background: Although diabetes mellitus (DM) can be treated with islet transplantation, a scarcity of donors limits the utility of this technique. This study investigated whether human mesenchymal stem cells (MSCs) from umbilical cord could be induced efficiently to differentiate into insulin-producing cells. Secondly, we evaluated the effect of portal vein transplantation of these differentiated cells in the treatment of streptozotocin-induced diabetes in rats. Methods: MSCs from human umbilical cord were induced in three stages to differentiate into insulin-producing cells and evaluated by immunocytochemistry, reverse transcriptase, and real-time PCR, and ELISA. Differentiated cells were transplanted into the liver of diabetic rats using a Port-A catheter via the portal vein. Blood glucose levels were monitored weekly. Results: Human nuclei and C-peptide were detected in the rat liver by immunohistochemistry. Pancreatic ?-cell development-related genes were expressed in the differentiated cells. C-peptide release was increased after glucose challenge in vitro. Furthermore, after transplantation of differentiated cells into the diabetic rats, blood sugar level decreased. Insulin-producing cells containing human C-peptide and human nuclei were located in the liver. Conclusion: Thus, a Port-A catheter can be used to transplant differentiated insulin-producing cells from human MSCs into the portal vein to alleviate hyperglycemia among diabetic rats.

AB - Background: Although diabetes mellitus (DM) can be treated with islet transplantation, a scarcity of donors limits the utility of this technique. This study investigated whether human mesenchymal stem cells (MSCs) from umbilical cord could be induced efficiently to differentiate into insulin-producing cells. Secondly, we evaluated the effect of portal vein transplantation of these differentiated cells in the treatment of streptozotocin-induced diabetes in rats. Methods: MSCs from human umbilical cord were induced in three stages to differentiate into insulin-producing cells and evaluated by immunocytochemistry, reverse transcriptase, and real-time PCR, and ELISA. Differentiated cells were transplanted into the liver of diabetic rats using a Port-A catheter via the portal vein. Blood glucose levels were monitored weekly. Results: Human nuclei and C-peptide were detected in the rat liver by immunohistochemistry. Pancreatic ?-cell development-related genes were expressed in the differentiated cells. C-peptide release was increased after glucose challenge in vitro. Furthermore, after transplantation of differentiated cells into the diabetic rats, blood sugar level decreased. Insulin-producing cells containing human C-peptide and human nuclei were located in the liver. Conclusion: Thus, a Port-A catheter can be used to transplant differentiated insulin-producing cells from human MSCs into the portal vein to alleviate hyperglycemia among diabetic rats.

KW - Insulin-producing cells

KW - Mesenchymal stem cell

KW - Portal vein

KW - Transplant

UR - http://www.scopus.com/inward/record.url?scp=84862182252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862182252&partnerID=8YFLogxK

U2 - 10.1186/1423-0127-19-47

DO - 10.1186/1423-0127-19-47

M3 - Article

C2 - 22545626

AN - SCOPUS:84862182252

VL - 19

JO - Journal of Biomedical Science

JF - Journal of Biomedical Science

SN - 1021-7770

IS - 1

M1 - 47

ER -